Susquehanna International Group’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.08M | Sell |
1,325,956
-43,061
| -3% | -$183K | ﹤0.01% | 4621 |
|
|
2025
Q4 | $4.94M | Sell |
1,369,017
-5,165
| -0.4% | -$22.5K | ﹤0.01% | 4041 |
|
|
2025
Q3 | $5.18M | Sell |
1,374,182
-245,565
| -15% | -$948K | ﹤0.01% | 4034 |
|
|
2025
Q2 | $6.27M | Buy |
1,619,747
+543,683
| +51% | +$2.94M | ﹤0.01% | 3578 |
|
|
2025
Q1 | $5.38M | Buy |
1,076,064
+575,145
| +115% | +$3.64M | ﹤0.01% | 3526 |
|
|
2024
Q4 | $3.61M | Sell |
500,919
-426,043
| -46% | -$3.25M | ﹤0.01% | 4118 |
|
|
2024
Q3 | $5.69M | Sell |
926,962
-1,283,439
| -58% | -$8.69M | ﹤0.01% | 3396 |
|
|
2024
Q2 | $14.7M | Buy |
2,210,401
+1,294,147
| +141% | +$9.55M | ﹤0.01% | 2057 |
|
|
2024
Q1 | $9.33M | Buy |
916,254
+183,000
| +25% | +$1.86M | ﹤0.01% | 2702 |
|
|
2023
Q4 | $8.25M | Buy |
733,254
+619,488
| +545% | +$2.59M | ﹤0.01% | 2906 |
|
|
2023
Q3 | $296K | Sell |
113,766
-65,252
| -36% | -$187K | ﹤0.01% | 9372 |
|
|
2023
Q2 | $632K | Sell |
179,018
-617,704
| -78% | -$2.77M | ﹤0.01% | 7758 |
|
|
2023
Q1 | $3.36M | Buy |
796,722
+444,649
| +126% | +$5.28M | ﹤0.01% | 4094 |
|
|
2022
Q4 | $5.79M | Buy |
352,073
+176,786
| +101% | +$1.99M | ﹤0.01% | 3018 |
|
|
2022
Q3 | $2.24M | Buy |
+175,287
| New | +$2.59M | ﹤0.01% | 4685 |
|
|
2022
Q2 | – | Sell |
-125,219
| Closed | -$772K | – | 12801 |
|
|
2022
Q1 | $763K | Sell |
125,219
-11,432
| -8% | -$84.2K | ﹤0.01% | 7844 |
|
|
2021
Q4 | $1.25M | Buy |
136,651
+51,174
| +60% | +$544K | ﹤0.01% | 6678 |
|
|
2021
Q3 | $967K | Sell |
85,477
-74,125
| -46% | -$901K | ﹤0.01% | 7645 |
|
|
2021
Q2 | $1.57M | Sell |
159,602
-169,382
| -51% | -$2.32M | ﹤0.01% | 6511 |
|
|
2021
Q1 | $4.65M | Buy |
328,984
+4,482
| +1% | +$72.5K | ﹤0.01% | 4039 |
|
|
2020
Q4 | $3.66M | Buy |
324,502
+214,753
| +196% | +$2.53M | ﹤0.01% | 3968 |
|
|
2020
Q3 | $1.45M | Buy |
+109,749
| New | +$2.19M | ﹤0.01% | 5243 |
|
|
2020
Q1 | – | Sell |
-17,976
| Closed | -$41.3K | – | 10172 |
|
|
2019
Q4 | $34K | Sell |
17,976
-2,572
| -13% | -$4.75K | ﹤0.01% | 9421 |
|
|
2019
Q3 | $40K | Sell |
20,548
-28,121
| -58% | -$62.3K | ﹤0.01% | 9840 |
|
|
2019
Q2 | $116K | Sell |
48,669
-8,891
| -15% | -$23.8K | ﹤0.01% | 9535 |
|
|
2019
Q1 | $167K | Buy |
+57,560
| New | +$172K | ﹤0.01% | 7974 |
|
|
2018
Q1 | – | Sell |
-819
| Closed | -$49K | – | 9252 |
|
|
2017
Q4 | $49K | Buy |
+819
| New | +$52.3K | ﹤0.01% | 8907 |
|
|
2017
Q3 | – | Sell |
-1,165
| Closed | -$112K | – | 8750 |
|
|
2017
Q2 | $112K | Buy |
1,165
+1,112
| +2,098% | +$185K | ﹤0.01% | 8635 |
|
|
2017
Q1 | $13K | Sell |
53
-300
| -85% | -$161K | ﹤0.01% | 8767 |
|
|
2016
Q4 | $344K | Buy |
+353
| New | +$316K | ﹤0.01% | 7714 |
|
|
2016
Q1 | – | Sell |
-40
| Closed | -$20.5K | – | 8947 |
|
|
2015
Q4 | $23K | Buy |
+40
| New | +$19.9K | ﹤0.01% | 9209 |
|
|
2015
Q3 | – | Sell |
-34
| Closed | -$18K | – | 9585 |
|
|
2015
Q2 | $18K | Sell |
34
-17
| -33% | -$8.59K | ﹤0.01% | 10008 |
|
|
2015
Q1 | $25K | Sell |
51
-70
| -58% | -$34.9K | ﹤0.01% | 9250 |
|
|
2014
Q4 | $66K | Sell |
121
-27
| -18% | -$13.9K | ﹤0.01% | 9305 |
|
|
2014
Q3 | $79K | Buy |
+148
| New | +$77.4K | ﹤0.01% | 9132 |
|
|
2014
Q1 | – | Sell |
-52
| Closed | -$30.4K | – | 8841 |
|
|
2013
Q4 | $29K | Sell |
52
-17
| -25% | -$10.1K | ﹤0.01% | 8870 |
|
|
2013
Q3 | $44K | Sell |
69
-23
| -25% | -$13.2K | ﹤0.01% | 8251 |
|
|
2013
Q2 | $44K | Buy |
+92
| New | +$45.6K | ﹤0.01% | 7997 |
|
Other funds holding ALT
VCM
VPM
N
Susquehanna International Group's ALT Position: Q1 2026 in Review
Susquehanna International Group reduced its Altimmune (ALT) stake by 3.1% in Q1 2026, selling an estimated $183K and leaving 1,325,956 shares worth $4.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4621.
Susquehanna International Group first reported a position in ALT in Q2 2013 and has held it in 38 quarters since. The position peaked at $14.7M in Q2 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.
- Susquehanna International Group held 1,325,956 shares of Altimmune worth $4.08M as of Q1 2026.
- Susquehanna International Group sold 43,061 Altimmune shares in Q1 2026, an estimated $183K.
- Altimmune made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4621 holding.
- Susquehanna International Group first reported a position in Altimmune in Q2 2013 and has held it in 38 quarters since.
- Susquehanna International Group's Altimmune position peaked at $14.7M in Q2 2024.
- 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.